Table 3 Subgroup analysis of patients who received macrolides
Outcome | BL-AZM (n = 74) | BL-CLR (n = 66) | P value |
|---|---|---|---|
Time to clinical stability (days) | 5 [3–7] | 3 [1–4.75] | < 0.0001 |
Clinical cure | 72 (97.3) | 56 (84.8) | 0.01 |
LOS (days) | 6.5 [5–9.25] | 8 [6–10.25] | 0.02 |
ICU admission | 0 (0) | 3 (4.5) | 0.06 |
In-hospital mortality | 0 (0) | 2 (3%) | 0.13 |
30 day readmission | 7 (9.5) | 6 (9.1) | 0.94 |
Elevation of liver enzymes | 22 (29.7) | 8 (12.1) | 0.01 |